IVERIC bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IVERIC bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2012 to Q1 2023.
  • IVERIC bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$72.2M, a 109% decline year-over-year.
  • IVERIC bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$223M, a 82.3% decline year-over-year.
  • IVERIC bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$185M, a 61.7% decline from 2021.
  • IVERIC bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$115M, a 35.5% decline from 2020.
  • IVERIC bio, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$84.5M, a 43.6% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$223M -$72.2M -$37.7M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$185M -$59.1M -$26M -78.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 -$159M -$42.4M -$17.8M -72.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$141M -$49.3M -$19.1M -63.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-04
Q1 2022 -$122M -$34.5M -$7.74M -28.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$115M -$33M -$7.6M -29.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$107M -$24.6M +$899K +3.53% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$108M -$30.1M -$11.6M -62.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$96.3M -$26.8M -$11.7M -77.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$84.5M -$25.4M -$7.95M -45.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$76.6M -$25.5M -$11M -76.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$65.6M -$18.6M -$4.15M -28.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$61.4M -$15.1M -$2.58M -20.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$58.9M -$17.5M -$122M -117% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $62.7M -$14.4M +$308K +2.09% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $62.4M -$14.4M -$1.23M -9.34% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-03
Q1 2019 $63.7M -$12.5M +$572K +4.38% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-03
Q4 2018 $63.1M $104M +$114M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 -$50.6M -$14.7M -$204M -108% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $153M -$13.2M +$9M +40.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 $144M -$13.1M +$30M +69.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 $114M -$9.54M +$56.7M +85.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $57.5M $189M +$250M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$193M -$22.2M +$7.74M +25.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$200M -$43.1M -$6.82M -18.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$193M -$66.3M -$30.6M -85.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$163M -$60.9M -$21.3M -53.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$141M -$29.9M +$7.19M +19.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$149M -$36.3M -$42.9M -647% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$106M -$35.6M -$4M -12.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 -$102M -$39.6M -$48.1M -563% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$53.6M -$37.1M +$35.9M +49.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$89.5M $6.64M +$27.3M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$117M -$31.7M -$11.3M -55.2% Oct 1, 2014 Dec 31, 2014 10-K/A 2015-07-28
Q3 2014 -$106M $8.55M +$24.7M Jul 1, 2014 Sep 30, 2014 10-K/A 2015-07-28
Q2 2014 -$130M -$73M -$63M -629% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$67.2M -$20.7M -$16.1M -348% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-07-28
Q4 2013 -$51.1M -$20.4M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$16.1M -$12M -288% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$10M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$4.62M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 -$4.15M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.